Federal Register / Vol. 63, No. 90 / Monday, May 11, 1998 / Notices 25863

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act.

Unless otherwise noted, nonbanking

activities will be conducted throughout

the United States.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than June 4, 1998.

A. Federal Reserve Bank of Chicago

(Philip Jackson, Applications Officer)

230 South LaSalle Street, Chicago,

Illinois 60690-1413:

1. Ploetz Investments Limited

Partnership, Prairie du Sac, Wisconsin;

to become a bank holding company by

acquiring 48.16 percent of the voting

shares of Bank of Prairie du Sac, Prairie

du Sac, Wisconsin.

Board of Governors of the Federal Reserve

System, May 5, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–12326 Filed 5–8–98; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Clinical Laboratory Improvement

Advisory Committee (CLIAC): Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meetings.

Name: Workgroup on Genetic Testing,

Clinical Laboratory Improvement Advisory

Committee.

Times and Dates: 8:30 a.m.–5 p.m., May

27, 1998; 8 a.m.–10 a.m., May 28, 1998.

Place: CDC, Auditorium B, Building 2,

1600 Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available. The room will

accommodate approximately 150 people.

Purpose: This Workgroup advises CLIAC

on issues related to Genetic Testing.

Matters To Be Discussed: The Workgroup

will review and discuss the Clinical

Laboratory Improvement Amendments

(CLIA) regulations and general or specific

CLIA requirements that apply to pre-analytic,

analytic, and post-analytic components of

genetic testing.

Agenda items are subject to change as

priorities dictate.

Name: Clinical Laboratory Improvement

Advisory Committee.

Times and Dates: 10:30 a.m.–5 p.m., May

28, 1998; 8:30 a.m.–5 p.m., May 29, 1998.

Place: CDC, Auditorium B, Building 2,

1600 Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available. The meeting room will

accommodate approximately 150 people.

Purpose: This committee is charged with

providing scientific and technical advice and

guidance to the Secretary of Health and

Human Services, the Assistant Secretary for

Health, and the Director, CDC, regarding the

need for, and the nature of, revisions to the

standards Page 3 under which clinical

laboratories are regulated; the impact of

proposed revisions to the standards; and the

modification of the standards to

accommodate technological advances.

Matters To Be Discussed: The agenda will

include an update on CLIA implementation;

general or specific CLIA requirements that

apply to pre-analytic, analytic, and postanalytic components of genetic testing; and

the applicability of CLIA to laboratory testing

performed for assisted reproductive

technology (ART).

The Committee solicits oral and written

testimony on the application of CLIA

regulations and ART. Requests to make an

oral presentation should be submitted in

writing to the contact person listed below by

close of business, May 22, 1998. All requests

to make oral comments should contain the

name, address, telephone number, and

organizational affiliation of the presenter.

Written comments should not exceed five

single-spaced, typed pages in length and

should be received by the contact person

listed below by close of business, May 22,

1998.

Agenda items are subject to change as

priorities dictate.

Contact Person for Additional Information:

John C. Ridderhof, Dr.P.H., Division of

Laboratory Systems, Public Health Practice

Program Office, CDC, 4770 Buford Highway,

NE, Mailstop G–25, Atlanta, Georgia 30341–

3724, telephone 770/488–8076, FAX 770/

488–1129.

Dated: April 30, 1998.

Julia M. Fuller,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 98–12235 Filed 5–8–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Citizens Advisory Committee on Public

Health Service (PHS) Activities and

Research at Department of Energy

(DOE) Sites: Idaho National

Engineering and Environmental

Laboratory Health Effects

Subcommittee

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Agency for Toxic

Substances and Disease Registry

(ATSDR) and the Centers for Disease

Control and Prevention (CDC) announce

the following meeting.

Name: Citizens Advisory Committee on

PHS Activities and Research at DOE Sites:

Idaho National Engineering and

Environmental Laboratory (INEEL) Health

Effects Subcommittee.

Times and Dates: 8:30 a.m.–5:15 p.m., June

2, 1998; 7:30 a.m.–5 p.m., June 3, 1998.

Place: Best Western Templin’s Hotel, 414

East First Avenue, Post Falls, Idaho 83854,

telephone 208/773–1611, FAX 208/773–

4192.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Background: Under a Memorandum of

Understanding (MOU) signed in December

1990 with DOE and replaced by an MOU

signed in 1996, the Department of Health and

Human Services (HHS) was given the

responsibility and resources for conducting

analytic epidemiologic investigations of

residents of communities in the vicinity of

DOE facilities, workers at DOE facilities, and

other persons potentially exposed to

radiation or to potential hazards from nonnuclear energy production use. HHS

delegated program responsibility to CDC.

In addition, an MOU was signed in October

1990 and renewed in November 1992